Eli Lilly has initiated legal proceedings against several wellness vendors for distributing illegal versions of its experimental weight-loss drug, retatrutide. The company filed six lawsuits on Wednesday in an effort to curb the growing online sale of these unauthorized products.
A spokesperson for Eli Lilly emphasized the importance of protecting consumers from buying and using untested and potentially unsafe versions of retatrutide. This move highlights the company’s commitment to maintaining the integrity of its research and ensuring that only approved, safe medications reach users.
The presence of illegal and unregulated versions of drugs can pose significant health risks. Eli Lilly’s action aims to safeguard the public and maintain regulatory standards.